...
首页> 外文期刊>Obstetrics and Gynecology International >Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol
【24h】

Primary Clear Cell Adenocarcinoma of the Cervix: A Clinical Analysis of 18 Cases without Exposure to Diethylstilbestrol

机译:子宫颈初级透明细胞腺癌:18例临床分析18例,没有暴露于二乙基胱

获取原文
           

摘要

Objectives. Cervical clear cell adenocarcinoma (CCAC) is a rare malignant tumor with independent biological behavior in the female reproductive system. In this report, we collect the clinical and histopathological characteristics of 18 CCAC patients without exposure to diethylstilbestrol (DES) and conduct relevant clinical analysis. Methods. We retrospectively analyzed the clinical data of 18 patients with CCAC who were diagnosed and treated from January 2009 to August 2017 in the Second Hospital of Jilin University. Results. A total of 18 patients were enrolled. The age of patients ranged from 37 to 74?years with the peak incidence between 45 and 55?years. The median age was 53?years. The most common symptom was vaginal bleeding (66.7%, 12/18). The most common type of lesion was the endocervical type (66.7%, 12/18). The negative rate of human papillomavirus (HPV) examination was 88.9% (8/9). Based on the staging criteria of the International Federation of Gynecology and Obstetrics (FIGO) cervical cancer clinical stage in 2018, 55.6% patients were stage I (n=10), 16.7% were stage II (n=3), 22.2% were stage III (n=4), and 5.6% were stage IV (n=1). Seventeen patients underwent surgery; 64.7% (11/17) of cases showed infiltration of the entire layer of the cervix, pelvic lymph node (PLN) metastasis was observed in 4 patients (26.7%, 4/15), endometrium metastasis was observed in 4 patients (25%, 4/16), and 13 patients (72.2%, 13/18) were diagnosed at an early stage (stage IB1-IIA2). Fifteen patients’ immunohistochemistry indicated that napsin A, CK7, CK (AE1/AE3), and PAX-8 were positive, and p53, p16, ER, and vimentin were expressed to different degrees. Follow-up data were obtained in 13 patients (72.2%, 13/18). One patient died of recurrence 5?months after surgery, and the other patients’ progression-free survival (PFS) ranged from 9 to 59?months. Tumor size (4?cm), tumor stage (FIGO IIA2-IV), PLN, and endometrium metastasis had negative effects on PFS (P0.05). Conclusions. CCAC is a highly invasive malignant tumor, whose pathogenesis may not be associated with HPV infection. Radical hysterectomy combined with chemotherapy (paclitaxel?+?platinum) has the ideal short-term curative effect. In the future, larger samples of clinical data are required to confirm these insights.
机译:目标。宫颈透明细胞腺癌(CCAC)是一种罕见的恶性肿瘤,具有雌性生殖系统中的独立生物学行为。在本报告中,我们收集18名CCAC患者的临床和组织病理特征,而不会暴露于二乙基胱螺旋(DES)并进行相关的临床分析。方法。我们回顾性分析了18例CCAC患者的临床资料,从2009年1月到2017年8月在吉林大学第二次诊断和治疗。结果。共有18名患者注册。患者的年龄范围为37至74岁,峰值发生在45%和55岁之间。中位年龄为53岁。年龄。最常见的症状是阴道出血(66.7%,12/18)。最常见的病变类型是内泌菌型(66.7%,12/18)。人乳头瘤病毒(HPV)检查的负率为88.9%(8/9)。根据2018年国际妇科和妇产科(FICO)宫颈癌临床阶段的分期标准,55.6%的患者是I阶段I(n = 10),16.7%是阶段II(n = 3),22.2%是阶段III(n = 4),5.6%是阶段IV(n = 1)。十七例患者接受手术; 64.7%(11/17)病例显示出整个子宫颈层的渗透,在4名患者中观察到骨盆淋巴结(PLN)转移(26.7%,4/15),在4名患者中观察到子宫内膜转移(25%) ,4/16)和13名患者(72.2%,13/18)被诊断为早期阶段(阶段IB1-IIA2)。十五名患者的免疫组化表明,鼻内A,CK7,CK(AE1 / AE3)和PAX-8为阳性,P53,P16,ER和Vimentin表示为不同程度。在13名患者中获得后续数据(72.2%,13/18)。一名患者在手术后5月份死亡5?几个月,其他患者的进展生存(PFS)范围为9至59个月。肿瘤大小(> 4?cm),肿瘤阶段(FIGO IIA2-IV),PLN和子宫内​​膜转移对PFS产生负面影响(P <0.05)。结论。 CCAC是一种高度侵入性的恶性肿瘤,其发病机制可能与HPV感染无关。激进子宫切除术与化疗(紫杉醇?+?铂)具有理想的短期疗效。将来,需要更大的临床数据样本来确认这些见解。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号